Company profile
Fortrea Holdings Inc.
NASDAQ: FTRE · Healthcare · Biotechnology
#95 of 1,418 Healthcare companies by revenue44th-percentile growth
EA Score
50DFH 52DQ 40GM 56SS 63
v0.1 · 65/100 weight · provisional
↑ workforce scale, growth stability · ↓ listing tenure, disclosure history
Methodology →Revenue TTM
$2.7B
Rev growth YoY (TTM)
+0.9%
Net income (FY)
-$986.2M
Employees
14,000
as of 2026-08-09
Market cap
$1.8B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.7B$2.7B2025
Net income-$986.2M-$986.2M2025
Operating income-$872.6M-$872.6M2025
Total assets$2.7B$2.7B2025
Liabilities$2.2B$2.2B2025
Equity$563.5M$563.5M2025
Revenue trend
FY2023 – FY2025 · USD
FY23
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Clinical Services100%
By geography
North America47%
Europe31%
Other Geographical Areas21%
The read
What is Fortrea Holdings Inc.’s revenue?
Fortrea Holdings Inc. booked $2.7B in FY2025 revenue, growing 1.0% year over year — about the middle of the pack among Healthcare companies we track, at a -36.2% net margin.
Peers · Healthcare
Accendra Health, Inc.62CAMN Healthcare Services, Inc.70BQuidelOrtho Corporation54DEnvista Holdings Corp73BInsulet Corp.83B+Bio-Rad Laboratories, Inc.84B+Neighbors
Durham →Key facts
CEOAnshul Thakral
SectorHealthcare
IndustryBiotechnology
HeadquartersDurham, NC
ExchangeNASDAQ: FTRE
Employees14,000
IPO date2023-06-20
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.